Holdings (43)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 11.65302433% |
| Cipla Ltd. | Healthcare | Equity | 5.81287543% |
| Ajanta Pharma Ltd. | Healthcare | Equity | 4.4021694% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 4.34823665% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 4.07061735% |
| Procter & Gamble Health Ltd. | Healthcare | Equity | 3.65476899% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 3.57280465% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 3.11632439% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 3.10377207% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 2.99075322% |
Returns and rankings
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund Returns | 22.13% | 20.15% | 23.62% | 14.85% |
| Category Average | 16.68% | 17.78% | 22.58% | NA% |
| Rank Within Category | 3.00% | 3.00% | 5.00% | NA% |
Expense ratio, exit load and tax
Expense ratio: 1.2%
Inclusive of GST
Exit load
Exit load of 1% if redeemed within 30 days.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.
Fund management
Education
Mr. Gada is B.com, CA, CS, & CFA
Experience
Prior to joining UTI Mutual Fund he has worked with BPCL as Senior Accounts Officer.